BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19155997)

  • 1. Tryptase mast cells in malignant pleural mesothelioma as an independent favorable prognostic factor.
    Alì G; Boldrini L; Lucchi M; Mussi A; Corsi V; Fontanini G
    J Thorac Oncol; 2009 Mar; 4(3):348-54. PubMed ID: 19155997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodality treatment of malignant pleural mesothelioma with or without immunotherapy: does it change anything?
    Lucchi M; Picchi A; Alí G; Chella A; Guglielmi G; Cristaudo A; Fontanini G; Mussi A
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):572-6. PubMed ID: 20053697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
    Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact.
    Alì G; Boldrini L; Lucchi M; Picchi A; Dell'Omodarme M; Prati MC; Mussi A; Corsi V; Fontanini G
    Br J Cancer; 2009 Dec; 101(11):1869-75. PubMed ID: 19935800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
    Neragi-Miandoab S; Richards WG; Sugarbaker DJ
    Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume.
    Gill RR; Richards WG; Yeap BY; Matsuoka S; Wolf AS; Gerbaudo VH; Bueno R; Sugarbaker DJ; Hatabu H
    AJR Am J Roentgenol; 2012 Feb; 198(2):359-63. PubMed ID: 22268178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma.
    Lu C; Perez-Soler R; Piperdi B; Walsh GL; Swisher SG; Smythe WR; Shin HJ; Ro JY; Feng L; Truong M; Yalamanchili A; Lopez-Berestein G; Hong WK; Khokhar AR; Shin DM
    J Clin Oncol; 2005 May; 23(15):3495-501. PubMed ID: 15908659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant pleural mesothelioma: surgical management in 285 patients.
    Schipper PH; Nichols FC; Thomse KM; Deschamps C; Cassivi SD; Allen MS; Pairolero PC
    Ann Thorac Surg; 2008 Jan; 85(1):257-64; discussion 264. PubMed ID: 18154820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis.
    Baud M; Strano S; Dechartres A; Jouni R; Triponez F; Chouaid C; Forgez P; Damotte D; Roche N; Régnard JF; Alifano M
    J Thorac Cardiovasc Surg; 2013 May; 145(5):1305-11. PubMed ID: 23072703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma.
    de Perrot M; McRae K; Anraku M; Karkouti K; Waddell TK; Pierre AF; Darling G; Keshavjee S; Johnston MR
    Ann Thorac Surg; 2008 Apr; 85(4):1206-10. PubMed ID: 18355497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and prognostic factors in malignant pleural mesothelioma: a retrospective study of 314 patients in the west part of Japan.
    Nojiri S; Gemba K; Aoe K; Kato K; Yamaguchi T; Sato T; Kubota K; Kishimoto T
    Jpn J Clin Oncol; 2011 Jan; 41(1):32-9. PubMed ID: 20798232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
    Sugarbaker DJ; Wolf AS; Chirieac LR; Godleski JJ; Tilleman TR; Jaklitsch MT; Bueno R; Richards WG
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer.
    Ibaraki T; Muramatsu M; Takai S; Jin D; Maruyama H; Orino T; Katsumata T; Miyazaki M
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):617-21. PubMed ID: 16125954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and survival in malignant pleural mesothelioma.
    Van Gelder T; Damhuis RA; Hoogsteden HC
    Eur Respir J; 1994 Jun; 7(6):1035-8. PubMed ID: 7925870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board.
    Kao SC; Vardy J; Chatfield M; Corte P; Pavlakis N; Clarke C; van Zandwijk N; Clarke S
    Clin Lung Cancer; 2013 Jan; 14(1):70-7. PubMed ID: 22658812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four-gene expression ratio test for survival in patients undergoing surgery for mesothelioma.
    Gordon GJ; Dong L; Yeap BY; Richards WG; Glickman JN; Edenfield H; Mani M; Colquitt R; Maulik G; Van Oss B; Sugarbaker DJ; Bueno R
    J Natl Cancer Inst; 2009 May; 101(9):678-86. PubMed ID: 19401544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma.
    Burt BM; Rodig SJ; Tilleman TR; Elbardissi AW; Bueno R; Sugarbaker DJ
    Cancer; 2011 Nov; 117(22):5234-44. PubMed ID: 21523763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma.
    Halstead JC; Lim E; Venkateswaran RM; Charman SC; Goddard M; Ritchie AJ
    Eur J Surg Oncol; 2005 Apr; 31(3):314-20. PubMed ID: 15780570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of occult disease in resection margin and lymph node after extrapleural pneumonectomy for malignant mesothelioma.
    Mineo TC; Ambrogi V; Pompeo E; Baldi A; Stella F; Aurea P; Marino M
    Ann Thorac Surg; 2008 May; 85(5):1740-6. PubMed ID: 18442576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy.
    Kao SC; Klebe S; Henderson DW; Reid G; Chatfield M; Armstrong NJ; Yan TD; Vardy J; Clarke S; van Zandwijk N; McCaughan B
    J Thorac Oncol; 2011 Nov; 6(11):1923-9. PubMed ID: 22011651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.